Austar Lifesciences Limited
AULSF
$0.02
-$0.05-71.43%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 61.28M | 60.69M | 45.77M | 45.50M | 55.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.28M | 60.69M | 45.77M | 45.50M | 55.57M |
| Cost of Revenue | 50.41M | 49.92M | 36.15M | 35.94M | 44.74M |
| Gross Profit | 10.87M | 10.77M | 9.62M | 9.56M | 10.83M |
| SG&A Expenses | 7.86M | 7.79M | 7.66M | 7.62M | 8.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -591.50K | -585.80K | -607.00K | -603.50K | -1.06M |
| Total Operating Expenses | 59.69M | 59.12M | 44.34M | 44.08M | 54.53M |
| Operating Income | 1.58M | 1.57M | 1.43M | 1.42M | 1.04M |
| Income Before Tax | 1.26M | 1.25M | 2.10M | 2.08M | 833.10K |
| Income Tax Expenses | 603.50K | 597.80K | 462.50K | 459.80K | 180.90K |
| Earnings from Continuing Operations | 653.60K | 647.30K | 1.63M | 1.62M | 652.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -32.40K | -32.10K | 95.80K | 95.20K | 56.90K |
| Net Income | 621.10K | 615.20K | 1.73M | 1.72M | 709.10K |
| EBIT | 1.58M | 1.57M | 1.43M | 1.42M | 1.04M |
| EBITDA | 2.67M | 2.64M | 2.44M | 2.42M | 2.18M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 512.58M | 512.58M | 512.58M | 512.58M | 512.58M |
| Average Diluted Shares Outstanding | 512.58M | 512.58M | 512.58M | 512.58M | 512.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |